Compare · BOAC vs MACA
BOAC vs MACA
Side-by-side comparison of Bluescape Opportunities Acquisition Corp. (BOAC) and Moringa Acquisition Corp (MACA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BOAC and MACA operate in Blank Checks (Finance), so they compete in similar markets.
- BOAC is the larger of the two at $743.4M, about 5.2x MACA ($143.8M).
Bluescape Opportunities Acquisition Corp.
Bluescape Opportunities Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Dallas, Texas.
Moringa Acquisition Corp
Moringa Acquisition Corp does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It focuses on pursuing opportunities in technology-based businesses or industries in Israel. The company was incorporated in 2020 and is based in New York, New York.
Latest BOAC
- SEC Form SC 13G/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- Bluescape Opportunities Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 25-NSE filed by Bluescape Opportunities Acquisition Corp.
- Bluescape Opportunities Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Bluescape Opportunities Acquisition Corp. Will Redeem its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Bluescape Opportunities Acquisition Corp.
- SEC Form 10-Q/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- SEC Form 10-K/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- SEC Form 10-Q filed by Bluescape Opportunities Acquisition Corp.
- SEC Form 10-K filed by Bluescape Opportunities Acquisition Corp.
Latest MACA
- PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
- Amendment: SEC Form SCHEDULE 13G/A filed by Moringa Acquisition Corp
- SEC Form 15-12G filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Moringa Acquisition Corp
- Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
- SEC Form 10-Q filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form DEFM14A filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits